Cai F

No ORCID on file · 7 papers in corpus · active 2011-2024

Study types

  • article 1
2024
Journal of vascular surgery. Venous and lymphatic disorders ·doi:10.1016/j.jvsv.2024.101945

ObjectiveThis study aimed to evaluate the effectiveness and safety of coils plus glue (CPG) in slope embankment technology vs coils plus sclerosant (CPS) in treating reflux-type pelvic venous disorders.MethodsThe analysis included patients …

2024
Science advances ·doi:10.1126/sciadv.ado7249

Ferroptosis, caused by disorders of iron metabolism, plays a critical role in various diseases, making the regulation of iron metabolism essential for tissue repair. In our analysis of degenerated intervertebral disc tissue, we observe a po…

2024
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-024-06016-6

ObjectiveThe aim of this study was to investigate whether the base of the tongue harbours a transformation zone (TZ), i.e., an initiation site for papillomavirus infection, analogous to that in the uterine cervix by examining the histologic…

2022
Trials ·doi:10.1186/s13063-022-06792-x

BackgroundAcute pancreatitis (AP) is a common digestive disease with increased incidence globally but without internationally licenced pharmacological therapy. Moderately severe and severe acute pancreatitis (MSAP/SAP) contributes predomina…

article 2022
Experimental and therapeutic medicine ·doi:10.3892/etm.2022.11601

Adenomyotic cysts are small cysts with a diameter of 1,000 U/ml) and CA125 (642 U/ml) and a complaint of pelvic pain. MRI scans were critical in diagnosing the case. Adhering to the principle of tumor-free implantation, a laparotomy was per…

2013
American journal of translational research

We conducted a prospective, randomized, and controlled trial to assess the optimal dose for GnRH antagonist, cetrorelix, for Chinese women during the course of ovarian stimulation. The patients were randomly divided into two groups, in whic…

2011
Journal of medicinal chemistry ·doi:10.1021/jm1014296

The crystal structure of LRH-1 ligand binding domain bound to our previously reported agonist 3-(E-oct-4-en-4-yl)-1-phenylamino-2-phenyl-cis-bicyclo[3.3.0]oct-2-ene 5 is described. Two new classes of agonists in which the bridgehead anilino…